Wang, M., Jurczak, W., Trneny, M., Belada, D., Wrobel, T., Ghosh, N., Keating, M.-m., Van Meerten, T., Alvarez, R., Von Keudell, G., Thieblemont, C., Peyrade, F., André, M., Hoffmann, M., Szafer‐glusman, E., Lin, J., Dean, J., Neuenburg, J., & Tam, C. (2026). Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 <scp>SYMPATICO</scp> study. British Journal of Haematology, 209(2), 734-739. https://doi.org/10.1111/bjh.70620 (Original work published 2026)